Wellcome Trust-funded stem cell research has produced red blood cells fit for transfusion into humans, paving the way for the mass production of blood
It is the stuff of gothic science fiction: men in white coats in factories of blood and bones.
But the production of blood on an industrial scale could become a reality once a trial is conducted in which artificial blood made from human stem cells is tested in patients for the first time.
It is the latest breakthrough in scientists’ efforts to re-engineer the body, which have already resulted in the likes of 3d-printed bones and bionic limbs.
Marc Turner, the principal researcher in the £5 million programme funded by the Wellcome Trust, told The Telegraph that his team had made red blood cells fit for clinical transfusion.
Prof Turner has devised a technique to culture red blood cells from induced pluripotent stem (iPS) cells – cells that have been taken from humans and ‘rewound’ into stem cells. Biochemical conditions similar to those in the human body are then recreated to induce the iPS cells to mature into red blood cells – of the rare universal blood type O-.
“Although similar research has been conducted elsewhere, this is the first time anybody has manufactured blood to the appropriate quality and safety standards for transfusion into a human being,” said Prof Turner.
There are plans in place for the trial to be concluded by late 2016 or early 2017, he said. It will most likely involve the treatment of three patients with Thalassaemia, a blood disorder requiring regular transfusions. The behaviour of the manufactured blood cells will then be monitored.
“The cells will be safe,” he said, adding that there are processes whereby cells can be removed.
The technique highlights the prospect of a limitless supply of manufactured type O- blood, free of disease and compatible with all patients.
The Latest on: Artificial blood
[google_news title=”” keyword=”Artificial blood” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial blood
- Artificial Sweetener Linked to Heritable Learning Deficits, Scientists Sayon September 22, 2023 at 4:32 am
"Our studies suggest that consuming only 10 to 15 percent of the maximum daily [recommended] dose could compromise mental health," Pradeep Bhide told Newsweek.
- Artificial Pancreas: What to Knowon September 21, 2023 at 5:38 am
An artificial pancreas can make a big difference in the day-to-day life of a person with type 1 diabetes. The Food and Drug Administration (FDA) has approved several versions. Type 1 diabetes is an autoimmune condition in which the body attacks the insulin-producing cells in the pancreas.
- Strengthening artificial immune cells to fight canceron September 20, 2023 at 12:34 pm
T» cells is proving extremely effective against certain blood cancers, but only in half of patients. A main reason for this is the premature dysfunction of these immune cells, which have been artificially modified in vitro.
- Global Artificial Blood Cells Market Size Worth $66.23 Million By 2030 | Latest Research Reporton September 18, 2023 at 6:47 am
The Global Artificial Blood Cells Market Market Report 2023 has been recently published by the Vantage Market Research. The report offers global demand, regional analysis, market trends ...
- Artificial Organs Produce Genuine Benefitson September 17, 2023 at 5:00 pm
The earliest attempts to make artificial organs focused on reproducing the mechanical functions of the body. The kidneys were basically just a blood filter, and the heart simply a four-chambered pump. The first artificial kidney was an external device ...
via Bing News